| Literature DB >> 27484364 |
Alex Steimle1, Kerstin Gronbach1, Brigitte Beifuss1, Andrea Schäfer1, Robin Harmening1, Annika Bender1, Jan Kevin Maerz1, Anna Lange1, Lena Michaelis1, Andreas Maurer2, Sarah Menz1, Kathy McCoy3, Ingo B Autenrieth1, Hubert Kalbacher4, Julia-Stefanie Frick5.
Abstract
Cathepsin S (CTSS) is a lysosomal protease whose activity regulation is important for MHC-II signaling and subsequent activation of CD4+ T cell mediated immune responses. Dysregulation of its enzymatic activity or enhanced secretion into extracellular environments is associated with the induction or progression of several autoimmune diseases. Here we demonstrate that commensal intestinal bacteria influence secretion rates and intracellular activity of host CTSS and that symbiotic bacteria, i.e. Bacteroides vulgatus mpk, may actively regulate this process and help to maintain physiological levels of CTSS activities in order to prevent from induction of pathological inflammation. The symbiont-controlled regulation of CTSS activity is mediated by anticipating reactive oxygen species induction in dendritic cells which, in turn, maintains cystatin C (CysC) monomer binding to CTSS. CysC monomers are potent endogenous CTSS inhibitors. This Bacteroides vulgatus caused and CysC dependent CTSS activity regulation is involved in the generation of tolerant intestinal dendritic cells contributing to prevention of T-cell mediated induction of colonic inflammation. Taken together, we demonstrate that symbionts of the intestinal microbiota regulate host CTSS activity and secretion and might therefore be an attractive approach to deal with CTSS associated autoimmune diseases.Entities:
Keywords: Autoimmune disease; Cathepsin S; Immunotherapy; Inflammatory bowel disease; Microbiota; Protease regulation
Mesh:
Substances:
Year: 2016 PMID: 27484364 DOI: 10.1016/j.jaut.2016.07.009
Source DB: PubMed Journal: J Autoimmun ISSN: 0896-8411 Impact factor: 7.094